Ventricular fibrillation as the presenting manifestation of adrenocortical carcinoma

American Heart Hospital Journal

Volumn 7, Issue 1, 2009, Pages 65-66

  Shimony, Avi ^a   Bereza, Sergiy ^a   Shalev, Aryeh ^a   Gilutz, Harel ^a   Ilia, Reuben ^a   Zahger, Doron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM; SPIRONOLACTONE;

ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; ALDOSTERONE RELEASE; AMBULATORY CARE; AMNESIA; ARTICLE; BLOOD PRESSURE; CASE REPORT; CLINICAL FEATURE; COLLAPSE; CORONARY CARE UNIT; DEFIBRILLATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FLANK PAIN; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RESUSCITATION; RETROPERITONEAL HEMATOMA; SUDDEN CARDIAC DEATH; ADRENAL CORTEX TUMOR; FATALITY; SUDDEN DEATH;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; DEATH, SUDDEN, CARDIAC; FATAL OUTCOME; HUMANS; MALE; VENTRICULAR FIBRILLATION;

EID: 73949103226     PISSN: 15419215     EISSN: 17517168     Source Type: Journal    
DOI: 10.15420/ahhj.2009.7.1.65     Document Type: Article

References (13)

1. Zipes PD, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society, Circulation, 2006;114:e385-e484
2. Scott BD, Friday KJ, Cushing's syndrome presenting as sudden death, Am Heart J, 1988;115(2):487-8
3. Kazumasa S, Yukio M, Yuki M, et al. QT prolongation with torsade de pointes in pheochromocytoma, Am Heart J, 1992;124(1):235-9
4. Liberthson RR, Sudden death from cardiac causes in children and young adults, N Engl J Med, 1996;334(16):1039-44
5. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age, Am J Cardiol, 1991;68(13):1388-92
6. Macdonald JE, Struthers AD, What is the optimal serum potassium level in cardiovascular patients?, J Am Coll Cardiol, 2004;43(2): 155-61
7. Abdo A, Bebb RA, Wilkins GE, Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism, Can J Cardiol, 1999;15:347-8
8. Sade E, Oto A, Oto A, et al. Adrenal adenoma presenting with torsade de pointes-a case report, Angiology, 2002;53(4):471-4
9. Geist M, Dorian P, Davies T, et al. Hyperaldosteronism and sudden cardiac death, Am J Cardiol, 1996;78:605-6
10. Furukawa A, Komatsu R, et al. Primary aldosteronism with ventricular fibrillation: a case report, J Cardiol, 2007;50(1):77-82
11. Messer CK, Kirschenbaum A, New MI, et al. Concomitant secretion of glucocorticoid, androgens, and mineralocorticoid by an adrenocortical carcinoma: case report and review of literature, Endocr Pract, 2007;13(4):408-12
12. Van Ditzhuijsen CI, van de Weijer R, Haak HR, Adrenocortical carcinoma, Neth J Med, 2007;65(2):55-60
13. Allolio B, Fassnacht M, Clinical review: Adrenocortical carcinoma: clinical update, J Clin Endocrinol Metab, 2006;91(6):2027-37